Company / Current Assets per Share
BioMarin Pharmaceutical Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$20.56
FY2025
5-year range
$12.51 / $20.56
FY2021-FY2025
Trend
+21.3%
vs FY2024
Sector context
#29 of 210
Health Care
What the data says
BioMarin Pharmaceutical's current assets per share of $20.56 is higher than 86% of companies in the Health Care sector (FY2025). Current Assets per Share has increased for 4 consecutive years, from $12.51 in FY2021 to $20.56 in FY2025.
Based on SEC 10-K filings.
20.56 in FY2025 with a 5-year CAGR of +9.8%. Top quartile in the Health Care sector.
Improved from $15.67 to $20.56 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +11.6%
- 5-Year CAGR
- +9.8%
- 10-Year CAGR
- -
Sector benchmark
-88.0% below sector average
Key checks
Key Insights
- BioMarin Pharmaceutical's current assets per share has grown for 4 consecutive years.
- In FY2025, current assets per share increased 21.3% year-over-year.
- Ranks #29 out of 210 companies in the Health Care sector.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.56 | +21.3% |
| FY2024 | $16.94 | +8.1% |
| FY2023 | $15.67 | +6.1% |
| FY2022 | $14.77 | +18.0% |
| FY2021 | $12.51 | -2.9% |
| FY2020 | $12.89 | +19.3% |
| FY2019 | $10.80 | -6.4% |
| FY2018 | $11.54 | -8.1% |
| FY2017 | $12.55 | +52.4% |
| FY2016 | $8.24 | +22.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026